N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance.

Autor: Hollander EE; Department of Medicine and.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Flock RE; Department of Biology and., McDevitt JC; Department of Medicine and.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Vostrejs WP; Department of Medicine and.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Campbell SL; Department of Medicine and.; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Orlen MI; Department of Medicine and.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kemp SB; Department of Medicine and.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kahn BM; Department of Medicine and.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Wellen KE; Department of Medicine and.; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kim IK; Department of Medicine and.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Stanger BZ; Department of Medicine and.; Abramson Cancer Center and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publikováno v: JCI insight [JCI Insight] 2024 May 23; Vol. 9 (12). Date of Electronic Publication: 2024 May 23.

The Emergence of Universal Immune Receptor T Cell Therapy for Cancer.

Autor: Minutolo NG; Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA, United States.; Pharmacology Graduate Group, University of Pennsylvania, Philadelphia, PA, United States.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, PA, United States., Hollander EE; Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, PA, United States.; Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, United States., Powell DJ Jr; Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, PA, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2019 Mar 26; Vol. 9, pp. 176. Date of Electronic Publication: 2019 Mar 26 (Print Publication: 2019).